K-V Investor Group Bumps Up Ch. 11 Offer To $275M
An investor group that has proposed a Chapter 11 plan that would allow it to take over K-V Pharmaceutical Co. upped its proposal to $275 million on Wednesday in New York...To view the full article, register now.
Already a subscriber? Click here to view full article